Spinocerebellar Ataxia Type 4
Neurology·MeSH: Optic Atrophy, Autosomal Dominant
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Spinocerebellar Ataxia Type 4?
There are 1 clinical trial targeting Spinocerebellar Ataxia Type 4 tracked by BioSniper.
What is the prevalence of Spinocerebellar Ataxia Type 4?
The estimated prevalence of Spinocerebellar Ataxia Type 4 is approximately 0.1 per 100,000 population.
Deep-dive into Spinocerebellar Ataxia Type 4
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis